Skip to main content

rilpivirine

Generic: RILPIVIRINE HYDROCHLORIDE·Brand: EDURANT, EDURANT PED, RILPIVIRINE HYDROCHLORIDE

rilpivirine: 1 clinical trial tracked.

rilpivirine evidence translation

What we can confirm

1 tracked trial

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about rilpivirine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

HIV Infections
Clinical Trials (1)

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Switching to Long-acting Antiretroviral Therapy of Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab in Combination With the Capsid Inhibitor Lenacapavir Twice-Yearly Versus Cabotegravir and Rilpivirine Every 8 Weeks in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

NCT07682961·Phase 3·GILD
Recruiting

Primary endpoint: Proportion of Participants With HIV-1 ribonucleic acid (RNA) ≥ 50 Copies/mL at Week 52 as Defined by the United States (US) Food and Drug Administration (FDA) Snapshot Algorithm.

InterventionalRandomizedopen590 targetStarted 2026-07Completion 2033-0319 sites · Australia, Japan, United StatesGilead Sciences